Clinical Trials Browser

OTHER × Lymphoma, Mantle-Cell × Tablets × Clear all

NCT04802590 2026-05-20

Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

Phase 2 Active not recruiting

Lymphoma, Mantle-Cell